Iron Deficiency in Heart Failure: Looking Beyond Anaemia

Heart Lung and Circulation

Volumn 25, Issue 3, 2016, Pages 209-216

  Wong, Christopher C Y ^a   Ng, Austin C C ^a   Kritharides, Leonard ^a   Sindone, Andrew P ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Heart failure; Intravenous iron; Iron deficiency

Indexed keywords

ANEMIA; CARDIOVASCULAR MORTALITY; CLINICAL TRIAL (TOPIC); COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; EXERCISE; HEART FAILURE; HEART FUNCTION; HUMAN; IRON DEFICIENCY; IRON METABOLISM; IRON THERAPY; NEW YORK HEART ASSOCIATION CLASS; OUTCOME ASSESSMENT; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; BLOOD; CHRONIC DISEASE; DEFICIENCY;

IRON;

CHRONIC DISEASE; HEART FAILURE; HUMANS; IRON;

EID: 84958123062     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2015.06.827     Document Type: Review

References (55)

1. Australian Institute of Health and Welfare. Cardiovascular disease: Australian facts 2011.Cardiovascular disease series. Cat. no. CVD 53. Canberra: AIHW.
2. Krum H, Jelinek M, Stewart S, Sindone A, Atherton J. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand. Guidelines for the prevention, detection and management of chronic heart failure in Australia, 2011.
3. Clark R., Mclennan S., Dawson A., Wilkinson D., Stewart S. Uncovering a Hidden Epidemic: A Study of the Current Burden of Heart Failure in Australia. Heart, Lung, and Circ. 2004, 13:266-273.
4. Australian Institute of Health and Welfare. Health system costs of cardiovascular diseases and diabetes in Australia 1993-94. Health and welfare expenditure series no. 5. Cat. no. HWE 11. Canberra: AIHW.
5. Ebner N., von Haehling S. Iron Deficiency in Heart Failure: A Practical Guide. Nutrients. 2013, 5:3730-3739.
6. Munoz M., Garcia-Erce J., Remacha A. Disorders of iron metabolism. Part 1: molecular basis of iron homoeostasis. J Clin Pathol. 2011, 64:281-286.
7. Deicher R., Hörl W. New insights into the regulation of iron homeostasis. Eur J Clin Invest. 2006, 36:301-309.
8. Jankowska E.A.H.S., Anker S.D., Macdougall I.C., Ponikowski P. Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives. Eur Heart J. 2013, 34:816-826.
9. Zimmermann M., Hurrell R. Nutritional iron deficiency. Lancet. 2007, 370:511-520.
10. Nemeth E., Ganz T. The Role of Hepcidin in Iron Metabolism. Acta Haematol. 2009, 122:78-86.
11. Wish J. Assessing iron status: beyond serum ferritin and transferrin saturation. Clin J Am Soc Nephrol. 2006, Suppl 1:S4-S8.
12. Goodnough L., Nemeth E., Ganz T. Detection, evaluation, and management of iron-restricted erythropoiesis. Blood. 2010, 116:4754-4761.
13. Gabay C., Kushner I. Acute-Phase Proteins and Other Systemic Responses to Inflammation. N Engl J Med. 1999, 340:448-454.
14. Cohen-Solal A., Leclercq C., Deray G., Lasocki S., Zambrowski J., Mebazaa A., et al. Iron deficiency: an emerging therapeutic target in heart failure. Heart. 2014, 100:1414-1420.
15. Nanas J., Matsouka C., Karageogopoulos D. Etiology of Anemia in Patients With Advanced Heart Failure. J Am Coll Cardiol. 2006, 48:2485-2489.
16. Cohen-Solal A., Leclercq C., Mebazaa A., Groote P., Damy T., Isnard R., et al. Diagnosis and treatment of iron deficiency in patients with heart failure: Expert position paper from French cardiologists. Arch Cardiovasc Dis. 2014, 107:563-571.
17. Pereira C., Roscani M., Zanati S., Matsubara B. Anemia, Heart Failure and Evidence-Based Clinical Management. Arq Bras Cardiol. 2012, 101:87-92.
18. Fitzsimons S., Doughty R. Iron deficiency in patients with heart failure. Eur Heart J: Cardiovascular Pharmacotherapy. 2015, 1:58-64.
19. Anker S., Colet J., Filippatos G., Willenheimer R., Dickstein K., Drexler H., et al. Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency. N Engl J Med. 2009, 361:2436-2448.
20. McMurray J., Adamopoulos S., Anker S., Auricchio A., Bohm M., Dickstein K., et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur Heart J. 2012, 33:1787-1847.
21. Hughes C., Woodside J., McGartland C., Roberts M., Nicholls D., McKeown P. Nutritional intake and oxidative stress in chronic heart failure. Nutr Metab Cardiovasc Dis. 2012, 22:376-382.
22. van Veldhuisen D., Anker S., Ponikowski P., Macdougall I. Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches. Nat Rev Cardiol. 2011, 8:485-493.
23. Arora N., Ghali J. Iron deficiency anemia in heart failure. Heart Fail Rev. 2013, 18:485-501.
24. Naito Y., Tsujino T., Fujimori Y., Hisashi S., Hirokuni A., Shinichi H., et al. Impaired expression of duodenal iron transporters in Dahl salt-sensitive heart failure rats. J Hypertension. 2011, 29:741-748.
25. Suzuki T., Hanawa H., Jiao S., Ohno Y., Hayashi Y., Yoshida K., et al. Inappropriate Expression of Hepcidin by Liver Congestion Contributes to Anemia and Relative Iron Deficiency. J Cardiac Fail. 2014, 20:268-277.
26. Ohno Y., Hanawa H., Jiao S., Hayashi Y., Yoshida K., Suzuki T., et al. Liver Congestion in Heart Failure Contributes to Inappropriately Increased Serum Hepcidin despite Anemia. Tohoku J Exp Med. 2015, 235:69-79.
27. Jankowska E., Malyszko J., Ardehali H., Koc-Zorawska E., Banasiak W., von Haehling S., et al. Iron status in patients with chronic heart failure. Eur Heart J. 2013, 34:827-834.
28. Jankowska E., Rozentryt P., Witkowska A., Nowak J., Hartmann O., Ponikowska B., et al. Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J. 2010, 31:1872-1880.
29. Okonko D., Mandal A., Missouris C., Poole-Wilson P. Disordered Iron Homeostasis in Chronic Heart Failure. JACC 2011, 58:1241-1251.
30. Kasner M., Aleksandrov A., Westermann D., Lassner D., Gross M., von Haehling S., et al. Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction. Int J Cardiol. 2013, 168:4652-4657.
31. Klip I., Comin-Colet J., Voors A., Ponikowski P., Enjuanes C., Banasiak W., et al. Iron deficiency in chronic heart failure: An international pooled analysis. Am Heart J. 2013, 165:575-582.
32. Parikh A., Natarajan S., Lipsitz S., Katz S. Iron Deficiency in Community-Dwelling U.S. Adults with Self- Reported Heart Failure in NHANES III: Prevalence and Associations with Anemia and Inflammation. Circ Heart Fail. 2011, 4:599-606.
33. Beard J. Iron Biology in Immune Function, Muscle Metabolism and Neuronal Functioning. J Nutr. 2001, 131:S568-S579.
34. Cairo G., Bernuzzi F., Recalcati S. A precious metal: iron, an essential nutrient for all cells. Genes Nutr. 2006, 1:25-39.
35. Jankowska E., Ponikowski P. Molecular Changes in Myocardium in the Course of Anemia or Iron Deficiency. Heart Fail Clin. 2010, 6:295-304.
36. Willis W., Gohil K., Brooks G., Dallman P. Iron Deficiency: Improved Exercise Performance Within 15 Hours of Iron Treatment in Rats. J Nutr. 1990, 120:909-916.
37. Naito Y., Tsujino T., Matsumoto M., Sakoda T., Ohyanagi M., Masuyama T. Adaptive response of the heart to long-term anemia induced by iron deficiency. Am J Physiol Heart Circ Physiol. 2009, 296:585-593.
38. Jankowska E., Rozentryt P., Witkowska A., Nowak J., Hartmann O., Ponikowska B., et al. Iron Deficiency Predicts Impaired Exercise Capacity in Patients With Systolic Chronic Heart Failure. J Cardiac Fail. 2011, 17:899-906.
39. Comin-Colet J., Enjuanes C., Gonzalez G., Ainhoa T., Merce C., Oona M., et al. Iron deficiency is a key determinant of health related quality of life in patients with chronic heart failure regardless of anaemia status. Eur J Heart Fail. 2013, 15:1164-1172.
40. Enjuanes C., Klip I., Bruguera J., Cladellas M., Ponikowski P., Banasiak W., et al. Iron deficiency and health-related quality of life in chronic heart failure: Results from a multicenter European study. Int J Cardiol. 2014, 174:268-275.
41. Aung N., Ling H., Cheng A., Aggarwal S., Flint J., Mendonca M., et al. Expansion of the red cell distribution width and evolving iron deficiency as predictors of poor outcome in chronic heart failure. Int J Cardiol. 2013, 168:1997-2002.
42. Bolger A., Bartlett F., Penston H., O'Leary J., Pollock N., Kaprielian R., et al. Intravenous Iron Alone for the Treatment of Anemia in Patients With Chronic Heart Failure. J Am Coll Cardiol. 2006, 48:1225-1227.
43. Usmanov R., Zueva E., Silverberg D., Shaked M. Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency. J Nephrol. 2008, 21:236-242.
44. Gaber R., Kotb N., Ghazy M., Nagy H., Salama M., Elhendy A. Tissue Doppler and Strain Rate Imaging Detect Improvement of Myocardial Function in Iron Deficient Patients with Congestive Heart Failure after Iron Replacement Therapy. Echocardiography. 2012, 29:13-18.
45. Okonko D., Grzeslo A., Witkowski T., Mandal A., Slater R., Roughton M., et al. Effect of Intravenous Iron Sucrose on Exercise Tolerance in Anemic and Nonanemic Patients With Symptomatic Chronic Heart Failure and Iron Deficiency. J Am Coll Cardiol. 2008, 51:103-112.
46. Toblli J., Lombrana A., Duarte P., Gennaro F. Intravenous Iron Reduces NT-Pro-Brain Natriuretic Peptide in Anemic Patients With Chronic Heart Failure and Renal Insufficiency. J Am Coll Cardiol. 2007, 50:1657-1665.
47. Beck-da-Silva L., Piardi D., Soder S., Rohde L., Pereira-Barretto A., Albuquerque D., et al. IRON-HF study: A randomized trial to assess the effects of iron in heart failure patients with anemia. Int J Cardiol. 2013, 168:3439-3442.
48. Ponikowski P., van Veldhuisen D., Comin-Colet J., Ertl G., Komajda M., Mareev V., et al. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. Eur Heart J. 2014, 10.1093/eurheartj/ehu385.
49. Toblli J., Gennaro F., Rivas C. Changes in Echocardiographic Parameters in Iron Deficiency Patients with Heart Failure and Chronic Kidney Disease Treated with Intravenous Iron. Heart, Lung, and Circ. 2015 Jan 21, pii: S1443-9506(15)00034-7. http://dx.doi.org/10.1016/j.hlc.2014.12.161.
50. Gutzwiller F., Schwenkglenks M., Blank P., Braunhofer P., Mori C., Szucs T., et al. Health economic assessment of ferric carboxymaltose in patients with iron deficiency and chronic heart failure based on the FAIR-HF trial: an analysis for the UK. Eur J Heart Fail. 2012, 14:782-790.
51. Comin-Colet J., Rubio-Rodriguez D., Rubio-Terres C., Enjuanes C., Gutzwiller F., Anker S., et al. A Cost-effectiveness Analysis of Ferric Carboxymaltose in Patients With Iron Deficiency and Chronic Heart Failure in Spain. Rev Esp Cardiol (Engl Ed). 2015, pii: S1885-5857(14)00462-9. doi:10.1016/j.rec.2014.10.010. [Epub ahead of print].
52. Lim E., Sohn H., Lee H., Choi S. Cost-utility of ferric carboxymaltose (Ferinject®) for iron-deficiency anemia patients with chronic heart failure in South Korea. Cost Eff Resour Alloc. 2014, 10.1186/1478-7547-12-19.
53. Hofmarcher T., Borg S. Cost-effectiveness analysis of ferric carboxymaltose in iron-deficient patients with chronic heart failure in Sweden. J Med Econ. 2015, 1-10. [Epub ahead of print].
54. Caira C., Ansalone G., Mancone M. Heart failure and iron deficiency anemia in Italy: results from CARMES-1 registry. Future Cardiol. 2013, 9:437-444.
55. Silverberg D., Schwatz D., Schwartz I., Assa E. The missed opportunities to diagnose and treat iron deficiency in patients hospitalized with heart failure. Int J Cardiol. 2013, 168:2164-2166.